Accendra Health schedules November 5 results for Accendra Health stock
Published on 10/27/2026 at 19:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSReporting date and analyst target
- Accendra Health scheduled third-quarter results for November 5, 2026.
- The average analyst target fell to USD 1.29 on October 23, 2026.
- Accendra Health stock costs EUR 0.18 at Lang & Schwarz on October 27, 2026 at 7:46 p.m. CET.
Accendra Health (ISIN US6907321029) has scheduled its third-quarter 2026 results for November 5, 2026, after trading ends on the New York Stock Exchange, according to Business Wire. Accendra Health stock was trading at EUR 0.18 at Lang & Schwarz on October 27, 2026 at 7:46 p.m. CET.
Analyst target falls to USD 1.29
The average one-year analyst target was cut to USD 1.29 from USD 1.54 on October 23, 2026, a 16.53 percent reduction, according to Nasdaq. The same report listed targets from USD 0.50 to USD 1.84 and said the average target was based on aggregated analyst estimates.
Second-quarter loss sets the backdrop
Accendra Health reported USD 613.23 million in second-quarter 2026 revenue and a USD 89.07 million net loss. The company also guided to full-year 2026 revenue of USD 2.45 billion to USD 2.55 billion and adjusted EBITDA of USD 300.00 million to USD 320.00 million, according to the Yahoo Finance transcript of the August 10, 2026 earnings call.
What does November 5 mean?
The next report will test whether the company's cost reductions and payer-collection measures are improving the financial profile. Management said second-quarter adjusted EBITDA exceeded USD 60.00 million, while the collection-rate issue reduced adjusted EBITDA by approximately USD 20.00 million in the first half of 2026, according to Yahoo Finance.
Accendra Health's trading frame
The stock's market capitalization was USD 15.8 million as of October 27, 2026. Its 52-week range was USD 0.19 to USD 5.52, and trading volume reached 840,744 shares on the same date. The wide range puts the EUR 0.18 Lang & Schwarz quotation in a highly volatile setting.
Price and reporting date
The November 5 release is the next scheduled corporate event. Accendra Health operates home-based healthcare businesses through its Apria and Byram brands, serving chronic and complex care needs.
Market context: Market report S&P 500.
